Toxicol in Vitro 57:211216
Semaglutide commonly causes nausea, vomiting, diarrhea, and constipation, especially during the early weeks of treatment
When to contact your GP or diabetes specialist nurse: If you've been taking expired Rybelsus and notice worsening blood glucose control If you experience unexplained symptoms such as persistent thirst, increased urination, or fatigue If you're unable to obtain a fresh supply of your medication For advice on alternative diabetes management strategies if Rybelsus is temporarily unavailable Seek urgent medical advice (call NHS 111) or emergency care (999) if you experience: Severe dehydration (extreme thirst, dry mouth, little or no urination) Confusion or drowsiness Rapid breathing Severe abdominal pain or persistent vomiting Very high blood glucose levels that don't respond to usual treatment These could be signs of severe hyperglycaemia or hyperosmolar hyperglycaemic state (HHS), which requires immediate medical attention
There is no universally recommended human dosing protocol for BPC-157, no established cycle length, and no clinically confirmed injection frequency
Work with your provider to ensure appropriate ongoing thyroid monitoring based on your specific condition